Cytotoxicity of Yellow Fever Specific CD8 T Cells Following YF-17D Vaccination
NCT04083430
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Healthy
Cytotoxicity
Yellow Fever Vaccination Reaction
Interventions
DRUG:
Yellow Fever Vaccine
Sponsor
University of Aarhus